Adam Procopio

Adam Procopio is a distinguished scientist with extensive experience at Merck since August 1999, currently serving in an Executive Director equivalent role with expertise in Business Development and Licensing due diligence across various drug modalities. Key responsibilities include advising senior executives and leading significant transactions since 2021. Previous roles encompass leadership in sterile formulation sciences, monoclonal antibody product development, and innovations in manufacturing technologies such as 3D printing. Adam also has a background in academia, having served as a visiting lecturer at the University of Delaware and an adjunct professor at Drexel University, where courses focused on materials science and mechanical behavior. Adam earned a Ph.D. in Materials Science and Engineering from Drexel University and holds both a BS and MS in the same field.